Preferred Label : Neurodegeneration with brain iron accumulation 4;
Symbol : NBIA4;
CISMeF acronym : MPAN; NBIA4;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : MPAN; Mitochondrial protein-associated neurodegeneration;
Description : Neurodegeneration with brain iron accumulation-4 (NBIA4) is an autosomal recessive
neurodegenerative disorder characterized by progressive spastic paraplegia, parkinsonism
unresponsive to L-DOPA treatment, and psychiatric or behavioral symptoms. Other neurologic
features, including optic atrophy, eye movement abnormalities, dystonia, dysphagia,
dysarthria, and motor axonal neuropathy, may occur. Brain MRI shows T2-weighted hypointensities
in the globus pallidus and substantia nigra. Onset is usually in the first 2 decades,
but later onset has been reported (summary by Dogu et al., 2013). There is phenotypic
variation: some patients may not have extrapyramidal signs and may have muscle weakness
and atrophy as well as cognitive impairment or developmental delay (Deschauer et al.,
2012) For a general phenotypic description and a discussion of genetic heterogeneity
of NBIA, see NBIA1 (234200).;
Inheritance : Autosomal recessive; Autosomal dominant;
Molecular basis : Caused by mutation in the chromosome 19 open reading frame 12 gene (C19ORF12, 614297.0001);
Laboratory abnormalities : Increased serum creatine kinase, mild;
Prefixed ID : #614298;
Origin ID : 614298;
UMLS CUI : C3280371;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT